Brahmi's therapeutic uses
Brahmi, specifically referring to Bacopa monnieri, is a traditional herb widely utilized in South Asian medicine, particularly Ayurveda, for its potential cognitive benefits. Commonly touted as a "brain tonic," Brahmi is primarily associated with enhancing memory and mental function. Its therapeutic applications extend beyond cognitive enhancement, suggesting possible benefits for conditions such as allergies, asthma, depression, anxiety, and ulcers, although evidence supporting these uses varies in strength and reliability.
The active compounds in Brahmi, known as bacosides, are believed to contribute to its purported health effects. While some studies have hinted at memory improvement, the scientific evidence remains inconclusive, with inconsistent findings across various trials. Recent research may indicate more consistent positive effects on cognitive function, particularly in memory and attention, but the need for further rigorous studies is evident.
Generally considered safe, Brahmi lacks significant side effects; however, its safety profile in vulnerable populations—such as children, pregnant or nursing women, and individuals with severe liver or kidney issues—has not been fully established. As such, individuals interested in Brahmi's therapeutic uses are encouraged to consult healthcare professionals before incorporating it into their health regimen.
Brahmi's therapeutic uses
- DEFINITION: Natural plant product used to treat specific health conditions.
- PRINCIPAL PROPOSED USE: Enhancing memory and mental function
- OTHER PROPOSED USES: Allergies, asthma, depression, hypothyroidism, narcotic addiction, ulcers, stress and anxiety relief, antioxidant, anti-inflammatory
Overview
Bacopa monnieri is a creeping perennial with white or blue flowers that grows throughout much of South Asia. It has been used traditionally to treat epilepsy, depression, insomnia, and schizophrenia. In the traditional medicine of India, Ayurveda, B. monnieri is considered to fall in the “Brahmi” category of herbs, a group of substances said to assist the mind and enhance awareness. From this comes B. monnieri’s common name of Brahmi, even though many other herbs also fall into the Brahmi category.
Therapeutic Dosages
The proposed active ingredients in B. monnieri are substances called bacosides. A typical dose of B. monnieri used in the studies described below was 300 to 450 mg daily of a concentrated alcohol extract standardized to bacoside content, equivalent to about 6 to 9 grams of whole dried herb.
Therapeutic Uses
B. monnieri is widely marketed as a “brain tonic” for enhancing memory and mental function. However, as discussed in the next section, the evidence that it works remains weak at best.
Even weaker evidence, far too preliminary to rely upon, hints that B. monnieri might have potential value for allergies, asthma, narcotic addiction, hypothyroidism, depression, attention deficit hyperactivity disorder (ADHD), blood pressure, Alzheimer's disease, and ulcers. However, far more research is necessary before anyone can responsibly promote B. monnieri for these conditions.
Scientific Evidence
Although several double-blind, placebo-controlled studies have evaluated the potential value of B. monnieri for enhancing mental function, the results are far from conclusive. B. monnieri appears to have antioxidant properties in the brain, which could potentially lead to positive effects on mental function. However, a two-week, double-blind, placebo-controlled trial of seventy-six persons who tested the potential memory-enhancing benefits of B. monnieri generally failed to find much evidence of benefit. The only significant improvement seen among all the many measures used was in one that evaluated the retention of new information. While this may sound somewhat promising, it means almost nothing. When a study uses many different techniques to assess improvement, mere chance ensures that at least one of them will produce results. Properly designed studies should focus on one test of benefit alone (the “primary outcome measure”) that is selected prior to running the trial. “Fishing” for results among multiple tests is a highly suspect method. Similarly, a randomized trial involving forty-eight healthy older adult subjects found some memory-enhancing effects of B. monnieri compared with placebo, but the outcomes measured were too numerous to be meaningful.
Nonetheless, if several independent studies use multiple tests of improvement, and the pattern of response is reliably maintained, then the results begin to appear more significant. This does not seem to be the case with B. monnieri. In a previous double-blind, placebo-controlled study enrolling forty-six individuals, the use of B. monnieri over a two-week period again produced benefits, but in an entirely different pattern. In yet another double-blind, placebo-controlled study, this one involving thirty-eight people, short-term use of B. monnieri failed to produce any measurable improvements in memory. In addition, the use of combined Ginkgo biloba (120 milligrams, or mg) and B. monnieri (300 mg) has also failed to improve mental function. This type of inconsistency suggests that the limited benefits seen in some studies were due to chance.
Slightly more promising results have been seen in studies of a proprietary Ayurvedic mixture containing B. monnieri and about thirty other ingredients. However, these studies are generally not up to scientific standards.
In the twenty-first century, emerging studies began to show more consistent positive effects on cognitive function, particularly in areas of memory, attention, and information processing. A 2014 meta-analysis of nine studies and a 2024 study showed benefits for memory, cognitive function, and reduced stress and anxiety with B. monnieri extract use.
Safety Issues
There are few significant side effects associated with the use of B. monnieri. However, comprehensive safety studies have not been reported. Safety in young children, pregnant or nursing women, and people with severe liver or kidney disease has not been established.
Bibliography
"Brahmi." Drugs.com, 20 Apr. 2018, www.drugs.com/npc/brahmi.html. Accessed 21 Nov. 2024.
Fatima, Urooj, et al. "Pharmacological Attributes of Bacopa Monnieri Extract: Current Updates and Clinical Manifestation." Frontiers in Nutrition, vol. 9, 2022, p. 972379, doi.org/10.3389/fnut.2022.972379. Accessed 21 Nov. 2024.
Maher, B. F., et al. "The Acute Effects of Combined Administration of Ginkgo Biloba and Bacopa Monniera on Cognitive Function in Humans." Human Psychopharmacology, vol. 17, 2002, pp. 163-164.
Nathan, P. J., J. Clarke, et al. "The Acute Effects of an Extract of Bacopa Monniera (B. Monnieri) on Cognitive Function in Healthy Normal Subjects." Human Psychopharmacology, vol. 16, 2001, pp. 345-351.
Nathan, P. J., S. Tanner, et al. "Effects of a Combined Extract of Ginkgo Biloba and Bacopa Monniera on Cognitive Function in Healthy Humans." Human Psychopharmacology, vol. 19, 2004, pp. 91-96.
Raman, Ryan. “7 Emerging Benefits of Bacopa monnieri (Brahmi).” Healthline, 18 Aug. 2023, www.healthline.com/nutrition/bacopa-monnieri-benefits. Accessed 21 Nov. 2024.
Roodenrys, S., et al. "Chronic Effects of B. Monnieri (Bacopa Monnieri) on Human Memory." Neuropsychopharmacology, vol. 27, 2002, pp. 279-281.
Samiulla, D. S., D. Prashanth, and A. Amit. "Mast Cell Stabilising Activity of Bacopa monnieri." Fitoterapia, vol. 72, 2001, pp. 284-285.
Sherman, Asia. “Bacopa and the Brain: Study Highlights Mood and Memory Benefits.” NutraIngredients-USA.com, 29 Mar. 2024, www.nutraingredients-usa.com/Article/2024/03/29/bacopa-and-the-brain-study-highlights-mood-and-memory-benefits. Accessed 21 Nov. 2024.
Walker, Eric A., and Mark V. Pellegrini. “Bacopa Monnieri - StatPearls.” NCBI, 17 Mar. 2023, www.ncbi.nlm.nih.gov/books/NBK589635. Accessed 21 Nov. 2024.